SCL Science Past Earnings Performance

Past criteria checks 0/6

SCL Science's earnings have been declining at an average annual rate of -8.7%, while the Medical Equipment industry saw earnings growing at 16.7% annually. Revenues have been growing at an average rate of 26% per year.

Key information

-8.7%

Earnings growth rate

-3.9%

EPS growth rate

Medical Equipment Industry Growth22.7%
Revenue growth rate26.0%
Return on equity-10.3%
Net Margin-59.8%
Last Earnings Update30 Jun 2024

Recent past performance updates

No updates

Recent updates

Is SCL Science (KOSDAQ:246960) Using Too Much Debt?

May 21
Is SCL Science (KOSDAQ:246960) Using Too Much Debt?

Is InnoTherapy (KOSDAQ:246960) Using Debt In A Risky Way?

Apr 01
Is InnoTherapy (KOSDAQ:246960) Using Debt In A Risky Way?

InnoTherapy (KOSDAQ:246960) Has Debt But No Earnings; Should You Worry?

Dec 15
InnoTherapy (KOSDAQ:246960) Has Debt But No Earnings; Should You Worry?

Revenue & Expenses Breakdown

How SCL Science makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

KOSDAQ:A246960 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 243,059-1,8302,7451,235
31 Mar 242,269-4,4312,5631,231
31 Dec 231,322-5,0262,6621,235
30 Sep 23809-5,4502,4051,259
30 Jun 23625-7,7202,7251,314
31 Mar 23483-5,5842,9351,253
31 Dec 22370-5,9723,0371,338
30 Sep 22349-7,0873,5631,358
30 Jun 22340-5,7523,4331,243
31 Mar 22425-5,4713,2461,500
31 Dec 21507-5,0293,0921,423
30 Sep 21539-3,0112,9461,447
30 Jun 21627-3,5492,7411,524
31 Mar 21612-3,2512,7121,246
31 Dec 20596-3,0472,6371,239
30 Sep 20657-3,7812,5991,178
30 Jun 20622-3,5292,4611,012
31 Mar 20668-3,5492,540979
31 Dec 19693-3,9893,169958
30 Sep 19711-3,6803,022964
30 Jun 19695-3,6033,065967
31 Mar 19578-3,3792,670973
31 Dec 18512-2,5741,908816
30 Sep 18382-2,9691,902675
30 Jun 18284-2,8381,844459
31 Mar 18257-2,8871,826498
31 Dec 17203-3,0121,724652
31 Dec 16101-7781,303334
31 Dec 1514-4,8231,012264
31 Dec 1442-79425111

Quality Earnings: A246960 is currently unprofitable.

Growing Profit Margin: A246960 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: A246960 is unprofitable, and losses have increased over the past 5 years at a rate of 8.7% per year.

Accelerating Growth: Unable to compare A246960's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: A246960 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (4%).


Return on Equity

High ROE: A246960 has a negative Return on Equity (-10.33%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies